NCT06626152View on ClinicalTrials.gov

Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial

PHASE2RecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2026

Conditions

Major Depressive Disorder

Interventions

DRUG

Apo-levocarb

As above.

Trial Locations (1)

V6Z 1Y6

RECRUITING

St. Paul's Hospital, Vancouver

All Listed Sponsors

collaborator

Providence Health & Services

OTHER

lead

University of British Columbia

OTHER